Boxer AL - Search Results

1

Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS.

Rosen HJ, Boeve BF, Boxer AL. Rosen HJ, et al. Among authors: boxer al. Alzheimers Dement. 2020 Jan;16(1):71-78. doi: 10.1002/alz.12004. Alzheimers Dement. 2020. PMID: 31914219 Free PMC article.

2

Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia.

Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ. Boxer AL, et al. Arch Neurol. 2003 Jul;60(7):949-56. doi: 10.1001/archneur.60.7.949. Arch Neurol. 2003. PMID: 12873851

3

Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment.

Boxer AL, Kramer JH, Du AT, Schuff N, Weiner MW, Miller BL, Rosen HJ. Boxer AL, et al. Neurology. 2003 Dec 9;61(11):1485-91. doi: 10.1212/01.wnl.0000090568.34810.47. Neurology. 2003. PMID: 14663029 Free PMC article.

4

Clinical and neuropsychological features of corticobasal degeneration.

Belfor N, Amici S, Boxer AL, Kramer JH, Gorno-Tempini ML, Rosen HJ, Miller BL. Belfor N, et al. Among authors: boxer al. Mech Ageing Dev. 2006 Feb;127(2):203-7. doi: 10.1016/j.mad.2005.09.013. Epub 2005 Nov 28. Mech Ageing Dev. 2006. PMID: 16310834 Review.

5

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ. Boxer AL, et al. Arch Neurol. 2006 Jan;63(1):81-6. doi: 10.1001/archneur.63.1.81. Arch Neurol. 2006. PMID: 16401739

6

Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies.

Boxer AL, Boeve BF. Boxer AL, et al. Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S79-87. doi: 10.1097/WAD.0b013e31815c345e. Alzheimer Dis Assoc Disord. 2007. PMID: 18090429 Review.

7

Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease.

Garbutt S, Matlin A, Hellmuth J, Schenk AK, Johnson JK, Rosen H, Dean D, Kramer J, Neuhaus J, Miller BL, Lisberger SG, Boxer AL. Garbutt S, et al. Among authors: boxer al. Brain. 2008 May;131(Pt 5):1268-81. doi: 10.1093/brain/awn047. Epub 2008 Mar 24. Brain. 2008. PMID: 18362099 Free PMC article.

8

An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration.

Boxer AL, Lipton AM, Womack K, Merrilees J, Neuhaus J, Pavlic D, Gandhi A, Red D, Martin-Cook K, Svetlik D, Miller BL. Boxer AL, et al. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7. doi: 10.1097/WAD.0b013e318197852f. Alzheimer Dis Assoc Disord. 2009. PMID: 19812461 Free PMC article. Clinical Trial.

9

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH; Tarenflurbil Phase 3 Study Group. Green RC, et al. JAMA. 2009 Dec 16;302(23):2557-64. doi: 10.1001/jama.2009.1866. JAMA. 2009. PMID: 20009055 Free PMC article. Clinical Trial.

10

Off-label medication use in frontotemporal dementia.

Bei Hu, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL. Bei Hu, et al. Among authors: boxer al. Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):128-33. doi: 10.1177/1533317509356692. Epub 2010 Feb 1. Am J Alzheimers Dis Other Demen. 2010. PMID: 20124256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page